138 related articles for article (PubMed ID: 14665614)
1. The phase III candidate: can we improve the science of selection?
Bajorin D
J Clin Oncol; 2004 Jan; 22(2):211-3. PubMed ID: 14665614
[No Abstract] [Full Text] [Related]
2. The ethics of early stopping rules.
Pater J; Goss P; Ingle J; Shelley W; Shepherd L
J Clin Oncol; 2005 Apr; 23(12):2862-3; author reply 2863-4. PubMed ID: 15838002
[No Abstract] [Full Text] [Related]
3. The ethics of early stopping rules: who is protecting whom?
Cannistra SA
J Clin Oncol; 2004 May; 22(9):1542-5. PubMed ID: 15117977
[No Abstract] [Full Text] [Related]
4. Health care disparity: an overlooked problem in phase I oncology trials.
O'Brien TE
J Clin Oncol; 2007 Jul; 25(21):3182-3. PubMed ID: 17634502
[No Abstract] [Full Text] [Related]
5. The emperor's new clothes or the current practice of clinical trials for multiple myeloma in the USA.
Ballester O
Cancer Invest; 2008 Jun; 26(5):445-7. PubMed ID: 18568765
[TBL] [Abstract][Full Text] [Related]
6. Phase III trials in oncology: setting standards of care?
Seeber S; Braun AH
Nat Clin Pract Oncol; 2005 Sep; 2(9):426-7. PubMed ID: 16264993
[No Abstract] [Full Text] [Related]
7. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
8. Improving the institutional submission and approval process for clinical research protocols in oncology.
Camacho LH; Marubio L; Purdom MA; Leonard D; Hong DS; Moulder S; Pilat SR; Kurzrock R
J Clin Oncol; 2007 Apr; 25(12):1632-3. PubMed ID: 17443009
[No Abstract] [Full Text] [Related]
9. Discrete event simulation applied to pediatric phase I oncology designs.
Barrett J; Skolnik J; Jayaraman B; Patel D; Adamson P
Clin Pharmacol Ther; 2008 Dec; 84(6):729-33. PubMed ID: 18923388
[No Abstract] [Full Text] [Related]
10. An efficient design for phase III studies of combination chemotherapies.
Ellenberg SS; Eisenberger MA
Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093
[No Abstract] [Full Text] [Related]
11. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer clinical trials.
Lerner SP
Urol Oncol; 2005; 23(4):275-9. PubMed ID: 16018944
[TBL] [Abstract][Full Text] [Related]
13. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
Steensma DP
J Clin Oncol; 2007 Mar; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
[No Abstract] [Full Text] [Related]
14. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
Bhutani M; Pathak AK
J Natl Cancer Inst; 2008 Sep; 100(18):1334; author reply 1334-5. PubMed ID: 18780866
[No Abstract] [Full Text] [Related]
15. Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
Ottaiano A; Mollo E; Di Lorenzo G; Pisano C; Di Maio M; Barletta E; Pensabene M; Segati R; Bullian P; Nasti G; Bryce J; Scala S; Castello G; Ascierto PA
Cancer Immunol Immunother; 2005 Jan; 54(1):44-50. PubMed ID: 15693138
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
[No Abstract] [Full Text] [Related]
17. Highlights from the 29th European Society for Medical Oncology Congress: Vienna, Austria, October 29 through November 2, 2004.
Price N
Clin Prostate Cancer; 2004 Dec; 3(3):136-40. PubMed ID: 15636678
[No Abstract] [Full Text] [Related]
18. Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going?
Booth CM; Tannock I
J Clin Oncol; 2008 Jan; 26(1):6-8. PubMed ID: 18165630
[No Abstract] [Full Text] [Related]
19. Decision making process in oncology practice: is the information available and what should it consist of?
Trédaniel J; Blay JY; Goldwasser F; Asselain B; Koscielny S; de Labareyre C; Balogh N; Bismut H; Misset JL; Marty M
Crit Rev Oncol Hematol; 2005 Jun; 54(3):165-70. PubMed ID: 15890267
[TBL] [Abstract][Full Text] [Related]
20. Searching for a standard.
Cohen EE; Vokes EE
J Clin Oncol; 2002 Jan; 20(2):359-61. PubMed ID: 11786560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
